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CD8+ T cells have been shown to capture plasma membrane fragments from target cells expressing their cognate antigen, a process
termed“trogocytosis”.Here,wereportthathumanCD4,theHumanImmunodeﬁciencyVirus(HIV)receptor,canbefoundamong
the proteins transferred by trogocytosis. CD4 is expressed in a correct orientation after its capture by CD8+ Tc e l l sa ss h o w nb y
its detection using conformational antibodies and its ability to allow HIV binding on recipient CD8+ T cells. Although we could
not ﬁnd direct evidence for infection of CD8+ T cells having captured CD4 by HIV, CD4 was virologically functional on these cells
as it conferred on them the ability to undergo syncytia formation induced by HIV-infected MOLT-4 cells. Our results show that
acquisition of CD4 by CD8+ T cells via trogocytosis could play a previously unappreciated role for CD8+ T cells in HIV spreading
possibly without leading to their infection.
1.Introduction
Trogocytosis refers to the process whereby lymphocytes
capture plasma membrane fragments from target cells
expressingtheircognateantigen[1].Amongthecomponents
conveyedbymembranefragmentsfromtargetcells,oneﬁnds
the antigen itself but also additional molecules including
costimulatory molecules, adhesion molecules, and various
receptors [2] which can confer novel functions to acceptor
lymphocytes. For instance, in the case of CD8+ CTL, capture
oftheantigenhasbeenshowntoresultintheirkillingbyCTL
sharing the same antigen-speciﬁcity, a phenomenon known
as fratricide and thought to be important for the contraction
of the CTL response [3]. Another kind of consequence is
that bystander captured molecules could help pathogens to
spread through the organism. Natural killer cells (NK cells),
which also perform trogocytosis, have recently been shown
to capture virus receptors such as CD21, the receptor for
Epstein-Barr virus (EBV) [4] and CD155, the receptor for
poliovirus [5]. Whether these receptors are fully functional
after their capture by NK cells remains unknown, but at least
in the case of the EBV receptors, we have shown that its
capture by NK cells confers them the ability to bind EBV [4].
The human CD4 antigen, the Human Immunodeﬁciency
Virus (HIV) receptor, has previously been shown to be
captured by CD8+ T cells in a rat [6] and in a mouse
[7] model. Recently, by comparing the capture of a whole
range of molecules associated to the plasma membrane,
we found that CD4 was actually among the molecules
that were most eﬃc i e n t l yc a p t u r e db ym u r i n eTa n dB
cells(manuscript submitted). Since trogocytosishad recently
been implicated in HIV propagation between CD4+ Tc e l l s
[8], we hypothesized that it could also play a role in the
virus spreading to CD8+ T cells. Indeed, CD8+ CTL play
an important role in the immune response against HIV
infection [9], since, until the virus escapes the immune
response, they are initially responsible for the elimination of
most CD4+ infected cells until the virus escapes the immune
response. Incidentally, it has been shown that during the late
stages of HIV infection, a minute fraction of CD8+ Tc e l l s
becomes infected [10] although the mechanism(s) leading
to infection is(are) unknown [11, 12]. Among the possible2 Journal of Biomedicine and Biotechnology
mechanisms leading to CTL infection, it has been proposed
that HIV could infect those CTL that express CD4 during
their activation [13–20]. A recent report also suggests that
CD8+CD4dim cells are enriched in anti-HIV lymphocytes
[21]. It should be noted, however, that CD4 expression is
not classically associated with the activation of CD8+ T
cells and that not all HIV-infected CD8+ T cells are CD4+,
suggesting that additional mechanisms may be involved.
It has also been argued that double-positive CD4+CD8+
thymocytes, which could end up as CD8+ T cells at the
end of their diﬀerentiation, could be targeted by HIV [22].
This hypothesis does, however, seem unlikely as a general
explanation for the occurrence of HIV-infected CD8+ T
cells because most of those are usually not na¨ ıve cells.
Finally, some HIV strains have been shown to use CD8 as
ar e c e p t o r[ 23] but these particular virions were only isolated
after many steps of enrichment, suggesting their very low
frequency in natural viral stocks. Of interest, De Maria et
al. reported that CD8+ T cells could be infected in culture,
provided that CD4+ T cells were present, suggesting that
direct contact between the two cells types is important for
CTL infection [24, 25]. Combined with the notion that
trogocytosis requires cell-to-cell contacts [2, 26], this last
observation suggests that it is worth investigating if CD8+
T cells could capture CD4 from CD4-expressing cells in a
coculture and, if so, whether this mechanism could result in
CD8+ T cell infection.
2.MaterialsandMethods
2.1. Cell Lines and Mice. The T2 human lymphoblastoid
cell line, which expresses HLA-A2.1 naturally, was used as
a target cell in antigen (Ag)-mediated trogocytosis exper-
iments. The mouse mastocytoma cell line P815, which
naturally expresses FcγRII/III, and their stable transfectants
expressing human CD4 fused or not to GFP were used as
target cells in experiments involving redirected trogocytosis
(i.e., trogocytosis triggered by antibodies (Ab)) [27]. The
human embryonic kidney 293 (HEK) cell line and the stable
transfectants of these cells expressing FcγRII/III and, for
some of them, CD4 fused or not to GFP were used in
the infection and syncytia formation assays. The human
T-lymphoblastoid MOLT-4/CCR5 cell line uninfected or
chronically infected with the NL4-3 HIV isolate (>90%
producing HIV particles) has been previously described [28]
and was used as a control in infection and in syncytia
experiments. The human CD8+ T cell line speciﬁc for the
CMV antigen N9V presented by HLA-A2.1 was a kind gift
of Dr. Christian Davrinche (Toulouse). Peripheral blood
cells from healthy blood donors were provided by the Banc
de Sang i de Teixits (BST, Barcelona, Spain) and obtained
after approval from the Ethical Committee of our research
center. Peripheral blood mononuclear cells (PBMC) were
puriﬁed by Ficoll density gradient, and immediately used to
purify CD8+ T cells (>95%) by immunomagnetic negative
selection (Miltenyi Biotec SL, Madrid, Spain). Purity of
isolated populations (>95%) was assessed by ﬂow cytometry
after CD4 and CD8 staining (BD Biosciences). All cell lines
were cultured in RPMI 1640 with 10% heat-inactivated fetal
bovine serum (FBS), penicillin-streptomycin (100U/mL),
and 2mM glutamine. Primary cells were cultured in RPMI
1640 medium supplemented with 10% heat inactivated fetal
calfserum(FBS,Invitrogen, Barcelona,Spain) in the absence
of any other stimuli.
2.2. Reagents, Antibodies, and Molecular Biology. The N9V
peptide (NLVPMVATV) was synthesized in our laboratory,
HPLC-puriﬁed (>98%) and its identity conﬁrmed by mass
spectrometry. Monoclonal Abs (mAb) against human CD3
(OKT3) and human CD28 (kind gift from Dr. Pedro
Romero) were obtained from hybridoma supernatants. The
unlabelled mAb against the murine FcγRII/III (2.4G2) was
produced in hybridoma supernatant. Fluorescent mAbs
against CD4 (RPA-T4) or CD8 (RPA-T8) were from
BD/Pharmingen. PE-labeled KC57 anti-HIV-p24 antigen
mAbwasfromBeckman&Coulter.Vectorsencodinghuman
CD4 or CD4-GFP have been described previously [29]. The
anti-CD4 mAb Leu3a was from Becton-Dickinson.
Trogocytosis assays were performed as previously
described [27] .T a r g e tc e l l sw e r ec e l ls u r f a c eb i o t i n y l a t e do r
not and incubated with eﬀector CD8+ Tc e l l s( E:T= 1:5 )
for 1 hour at 37◦C. For redirected trogocytosis experiments,
T cells were previously incubated with 10% of the anti-CD3
and anti-CD28 mAbs supernatants for 15 minutes at 4◦C
before incubation with target cells (P815 or HEK-FcR)
expressing human CD4 or CD4-GFP. In some assays, the
blocking anti-FcγRII/III mAb 2.4G2 was preincubated
with P815 cells before coculture with T cells. For Ag-
dependent trogocytosis experiments, the corresponding
N9V peptide (ﬁnal, saturating concentration = 1μM) was
incubated with T2 target cells before T cells were added.
At the end of the incubation period, T cells were then
analyzed by ﬂow cytometry on an FACSCalibur or LSRII
(Becton Dickinson) using an anti-CD8 mAb to gate on
the cells of interest and either ﬂuorescent streptavidin
(to detect biotin capture) or anti-CD4 RPA-T4 mAb (to
detect CD4 capture). The eﬃciency of membrane capture
was calculated as fold induction, that is, the median
ﬂuorescence intensity (MFI) of the molecule captured
by acceptor cells that were cocultured with donor cells
in the presence of the stimulus, divided by the MFI of
acceptor cells cultured with donor cells in the absence of any
stimulus.
2.3. Analysis of Sequential, Early Events of HIV Infection
2.3.1. HIV Binding to CD8+ TC e l l s .Chronically infected
MOLT-4/CCR5 cells (200,000 cells/well) were cultured in
96-well plates either alone (control) or with 200,000 CD8+
T cells that had beforehand acquired CD4 or not by
trogocytosis. Uninfected MOLT-4/CCR5 cells were used as
negative control and in some assays, the anti-CD4 mAb
Leu3a (0.25μg/mL) that blocks HIV binding to CD4 was
added. HIV particles associated to CD8+ T cells, which
corresponds to incoming virions transferred during cellular
contacts, were analyzed by ﬂow cytometry after 24 hours
of coculture. Fixed and permeabilized cells (Fix & Perm,
Caltag) were stained with a PE-Cy-7-labeled anti-CD8 andJournal of Biomedicine and Biotechnology 3
the PE-labeled KC57 anti-HIV-p24 mAbs. P24 staining was
analyzed in gated CD8+ T cells.
2.3.2. Analysis of Cell-to-Cell Fusion. In the cocultures
described above, we monitored the formation of multinu-
cleated giant cells (syncytia) resulting from the fusion of
HIV infected cells with cells expressing viral receptors after
24 hours of coculture. Syncytium formation was scored by
visualizing cultures in a Nikon Eclipse TE-200 microscope.
Random ﬁelds were photographed and syncytia counted in
at least four ﬁelds containing 500–600 cells.
2.3.3. Synthesis of Proviral DNA. In the same cocultures
analyzed for HIV capture and syncytium formation, the
newly synthesized proviral HIV DNA was quantiﬁed by real-
time PCR as previously described [29, 30].
2.4. Analysis of Productive Infection. As an alternative
approach to test the susceptibility of CD8+ T cells that had,
or not, previously captured CD4 by trogocytosis to HIV
infection, we performed classical cell-free virus infections.
Brieﬂy, 200,000 CD8+ T cells were incubated with a highly
infectious NL4-3 virus stock produced in PBMCs of healthy
donors (MOI = 1) in a ﬁnal volume of 200μl. All assays
were performed in 96-well plates using RPMI1640 medium
supplemented with 10% FBS. After 1, 3, and 5 days of
culture at 37◦C, supernatants were harvested and analyzed
by ELISA (Innogenetics, Barcelona, Spain) for p24 content,
as a measure of the production of HIV particles.
3. Results andDiscussion
3.1. A Human CD8+ T Cell Line Captures CD4 by Trogocytosis
from CD4+ Target Cells in the Presence of Their Cognate
Antigen and Expresses it in a Correct Conformation. We and
others have previously reported that CD4 was captured by
CD8+ T cells upon antigen recognition on CD4-expressing
target cells loaded with the cognate antigen recognized by
CD8+ T cells in both a mouse and rat model [6, 7]. First
we demonstrated that this was also true in a fully human
system. CD4+ human T2 cells were incubated or not with the
N9V antigen and washed thoroughly before incubation with
the human CD8+CD4− T cell line speciﬁc for N9V. The cells
were then analyzed by ﬂow cytometry. As shown in Figure 1,
after a 1-hour incubation period CD8+ T cells displayed
CD4 expression when they were cocultured with T2 cells
loaded with N9V but not in the absence of the antigen. Our
results strongly suggest that in human cells as well, CD4
expression by CD8+ T cells can be due to capture from
CD4-expressing T2 cells. Although it has occasionally been
shown that activated CD8+ T cells can express CD4 as an
activation marker [15, 18], whether this was due to de novo
synthesis or capture was not determined in most studies
where the expression of CD4 by CD8+ Tc e l l sw a sr e p o r t e d .
This can be easily explained by the fact that the phenomenon
of trogocytosis had not yet been described and characterized.
Infact,inallthestudiescitedabove[13,14,20,31],thelevels
of CD4 expression reported were quite low compared with
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Figure 1: Human CD8+ CTL speciﬁc for the cytomegalovirus N9V
Ag capture CD4 from T2 target cells. Human CD8+ Tc e l l sw e r e
incubated for 1 hour with T2 cells, which express CD4 and HLA-
A2.1 naturally, that had been loaded (+Ag) or not (−Ag) with the
N9V peptide. Cells were then analyzed by ﬂow cytometry for CD4
and CD8 expression. Shown are overlapping histograms of CD4
expression on gated CD8+ T cells. Similar results were obtained in 3
experiments.
thosedetectedonconventionalCD4+ Tcells,andwouldthus
be compatible with the acquisition of CD4 by trogocytosis.
IrrespectiveofthemechanisminvolvedinCD4expressionby
CD8+ T cells, it has been reported that CD8+CD4dim cells are
enriched in anti-HIV lymphocytes [21], which would make
these cells, which are by nature in frequent contacts with
HIV-infected cells, possible targets of HIV infection.
In our case, the fact that CD4 expression could be due
to de novo synthesis is unlikely since, in our system, CD4 is
expressed on CD8+ T cells after 1 hour of coincubation, or
even sooner (not shown).
In addition, as the CMV-speciﬁc CTL used had been
stimulated a few days earlier in the presence of PBMC and
antigen (i.e., in conditions where trogocytosis occurs), this
experiment measuring capture of CD4 shows a sequential
gain and loss of the material acquired by trogocytosis. As the
anti-CD4 mAb we used (clone RPA-T4) is conformational,
our results also imply that the CD4 is exposed in a correct
conformationtotheextracellularmilieuonthesurfaceofthe
CD8+ T cells.
3.2. Redirected Trogocytosis Experiments Allow Nonantigen
Speciﬁc CD8+ T Cells from Healthy Donors and HIV-Infected
Patients to Capture CD4. Because the experimental system
presented above is not easily amenable to manipulation and
is limited to one single antigen speciﬁcity, we exploited our
recent observation that trogocytosis could be triggered by
adding appropriate mAb in a coculture between T cells and
FcR-expressing cells [27]. As target cells, we used the murine
P815 cells naturally expressing FcR and generated stable
transfectants expressing either the human CD4 molecule
a l o n eo rf u s e dt oG F P .W eh a v ep r e v i o u s l yi d e n t i ﬁ e das e t
of mAbs that can trigger trogocytosis in human T cells4 Journal of Biomedicine and Biotechnology
(Daubeuf et al., manuscript submitted) and used the com-
bination of anti-CD3 + anti-CD28 to trigger both eﬃcient
trogocytosis and T cell activation. As shown in Figure 2,
coculture of activated CD8+CD4− T cells from healthy
donors with P815-CD4 or P815-CD4-GFP in the presence
of the anti-CD3 + anti-CD28 mAbs led to the capture of
biotinylated plasma membrane proteins (Figure 2(a)), and
in particular CD4-GFP (Figures 2(b) and 2(c))b yC D 8 +
T cells. Capture of CD4, and more generally of membrane
fragments, was inhibited when P815 cells were preincubated
with the blocking anti-FcγRII/III mAb 2.4G2. Furthermore,
no capture was detected in cocultures performed without
the anti-CD3 and anti-CD28 mAbs. The possibility that
CD4 expression by CD8+ T cells could result from de novo
expression was completely ruled out by the observation that,
for CD4-GFP, capture could be documented both with the
anti-CD4 mAb (Figure 2(b)) and based on GFP ﬂuorescence
(Figure 2(c)). The kinetics of CD4-GFP capture by trogocy-
tosis (the eﬃciency of which is expressed as fold induction)
show that CD8+ T cells have already acquired high level of
CD4-GFP after 30 minutes of coculture and that they express
transiently the captured molecules for a couple of hours,
before internalizing them (Figure 2(d)). The observation
that the curve of GFP detection is slightly shifted to the
right compared to that obtained with CD4 staining is not
surprising since the mAb used to detect CD4 can only stain
this molecule when it is present at the cell surface whereas
GFP will still be detectable after internalization. Similar
results were obtained when we used HEK cells transfected
with FcR and CD4 instead of P815 cells (not shown). In
additional experiments not shown here, we also documented
thatCD8+ TcellscouldcapturetheHIVcoreceptors,CXCR4
and CCR5, although CTL normally express both of these
molecules. Since CD4 is captured rapidly by CTL during
interactions with neighboring cells, and then lost relatively
rapidly (in less than 24 hours), detection of captured CD4
on CTL would identify those having recently been in contact
with CD4+ target cells. Although, for technical reasons,
we did not check the sequential gain and loss of CD4 in
the redirected-trogocytosis experimental setup, we suppose
that it occurs as suggested for the experiments using CMV-
speciﬁc CTL presented in Figure 1. This mechanism would
allow CD8+ T cells to increase the capture of CD4 during
multiple and occasional interactions with CD4+ target cells.
As the HIV infection progresses, it severely alters the
immune response, mainly by depleting the CD4+ T cells, but
also by disturbing the CTL functions [9]. Thus we wanted
to conﬁrm that CD8+ T cells from infected patients were
still able to perform trogocytosis. As shown in Figure 2(e),
CD8+ T cells obtained from the blood of an HIV+ patient by
negative selection captured CD4 from P815-CD4 cells when
the coculture was performed in the presence of the anti-CD3
+ anti-CD28 mAbs.
3.3. CD4 Captured by CD8+ T Cells Allows HIV Binding.
As CD4 is captured and expressed in an, a priori, correct
conformationbyCD8+ Tcells,wenextcheckedifthisfeature
conferred to CD8+ T cells the ability to bind HIV. To collect
CD8+ T cells after CD4 capture more easily, we used the
adherent cell line HEK-FcR stably transfected with human
CD4-GFP as CD4-donor cells. CD8+ T cells, preincubated or
not with mAb triggering trogocytosis, were cocultured with
HEK-FcR-CD4-GFP for 1 hour and were then harvested in
the supernatant (CD8+ Tc e l lp u r i t y> 95%, not shown).
These cells were directly cocultured with MOLT-4 cells
chronically infected or not with the NL4-3 HIV isolate. Note
that, before coculturing the CD8+ T cells with MOLT-4 cells,
we systematically conﬁrmed that they had acquired levels
of CD4 similar to what is shown on Figure 2 (not shown).
We have previously shown that incubation of HIV-infected
cells with uninfected CD4+ T cells induced a highly eﬃcient
binding of HIV to CD4, allowing the assessment of cell-to-
cell fusion events and the rapid quantiﬁcation of HIV entry
by real-time PCR [8, 29, 30]. Taking advantage of this rapid
and highly eﬃcient mode of HIV spread, we determined,
after 24 hours, the attachment of virions to CD8+ Tc e l l s
by ﬂow cytometry using an anti-p24 antibody. Although the
levels of staining were very faint, we detected reproducible
and signiﬁcant staining for p24 on CD8+ T cells having
acquired CD4 (open black histograms) when they had been
cocultured with HIV-infected MOLT-4 cells (Figure 3(b))
but not with uninfected MOLT-4 cells (Figure 3(a)). No
p24 staining could be detected on CD8+ T cells, which had
been cocultured with HIV-infected MOLT-4 cells but had
not acquired CD4 (open grey histograms). Interestingly, the
presence of the Leu3a blocking mAb in the coculture fully
inhibited the attachment of the virions (Figure 3(c)). Thus
our results show that CD4 capture by CD8+ T cells confers
on these cells the ability to bind HIV particles, and that this
virion binding is inhibited when the CD4 is not available.
This is reminiscent of our former observation that capture
of the EBV receptor CD21 by NK cells allow them to bind
the virus [4] and that more generally speaking, molecules
captured by trogocytosis are functional in terms of ligand
binding ([32] and references therein). Of note, although
capture of molecules by activated T cells in the absence
of stimulus (see [33] for instance) has been described, the
possibility that CD8+ T cells could capture CD4 from HIV-
infected MOLT-4 cells was ruled out, as these cells show
complete downregulation of CD4 [34].
3.4. CD8+ T Cells Having Captured CD4 by Trogocytosis
Induce Syncytia Formation in HIV-Infected MOLT-4 Cells.
Having observed the ability of captured CD4 to bind HIV
particles presented by MOLT-4 cells, we next evaluated
whether subsequent membrane fusion events could also
take place. Activated CD8+ T cells alone (not shown) or
cocultured with HEK cells lacking CD4 expression (Figure 4
upper panels) do not form syncytia in cocultures with
infected-MOLT-4. Interestingly, in the presence of CD8+ T
cells having acquired CD4, syncytia were massively formed,
a process that was abolished when the anti-CD4 Leu-3a
neutralizing mAb was added to the coculture (Figure 4
middle panels). The extent of syncytia formation was
dependent on trogocytic events, as it was strongly reduced
when the CD8+ T cells had been cultured with HEK-CD4-
GFP cells in the absence of mAbs triggering trogocytosis
(Figure 4 lower panels). Syncytia formation was strictlyJournal of Biomedicine and Biotechnology 5
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Figure 2: CD8+ T cells from healthy donors and HIV+ patients capture CD4 and membrane fragments from P815-CD4-GFP cells during
redirected trogocytosis. CD8+ T cells, immunomagnetically puriﬁed from human PBMC, were coated (grey open histogram) or not (black
close histogram) with anti-CD3 + anti-CD28 mAb, then incubated with P815 cells expressing human CD4 fused to GFP, which had been
previously cell surface biotinylated. (a) Cells were analyzed by ﬂow cytometry for biotin capture using ﬂuorescent streptavidin and CD8
expression. Shown are overlapping histograms of biotin detection on gated CD8+ T cells from healthy donor. Grey dotted open histogram
shows biotin capture by anti-CD3 + anti-CD28-coated CD8+ Tc e l l se x p o s e dt oF c γRII/III-coated P815 cells previously coated by 2.4G2
mAb. (b) As in (a) except that CD4 rather than biotin capture was determined and is shown on gated CD8+ T cells from healthy donor. (c)
As in (b) except that GFP rather than CD4 capture was determined and is shown on gated CD8+ T cells from healthy donor. (d) Kinetics of
the transfer eﬃciency of CD4-GFP on CD8+ T cells co-incubated with P815-CD4-GFP. Transfer of CD4-GFP on CD8+ T cells was detected
using anti-CD4 mAb (left panel) and GFP ﬂuorescence (right panel). Results show the fold-induction, that is, the CD4 or GFP ﬂuorescence
on CD8+ T cells obtained from cocultures in the presence of stimulatory anti-CD3 + CD28 mAb divided by those obtained in the absence of
stimulatory mAb. The experiments were performed in the presence (grey histograms) or absence (black histograms) of the blocking 2.4G2
mAb. (e) As in (b) except that CD8+ T cells were puriﬁed from PBMC of a-HIV-infected patient. Since we had only a few cells, we could
not perform the control experiment with the blocking 2.4G2 mAb. Note that, in each case, similar results were obtained in at least three
independent experiments.6 Journal of Biomedicine and Biotechnology
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Figure 3: CD8+ T having acquired CD4 bind HIV particles. (a) Expression of p24 on CD8+ T cells having captured (open black histogram)
or not (closed grey histogram) CD4 in a previous coculture (as shown in Figure 2 but target cells are HEK-FcR stably transfected with
human CD4) and incubated with uninfected MOLT-4 cells. Shown are overlaps of p24 staining on gated CD8+ T cells. (b) As in (a) except
that infected MOLT-4 cells were used in the coculture with CD8+ T cells. (c) As in (b) except that the Leu3a neutralizing anti-CD4 mAb
was present during the coculture. (d) Shown are overlap of p24 staining on uninfected MOLT-4 cells (as in condition shown in (a), open
black histograms) and on infected MOLT-4 cells (as in conditions shown in (b) and (c), closed black histograms). Note that MOLT-4 cells
were analyzed from the coculture with T cells and with the very same settings used for the analysis of T cells, which explains the high
autoﬂuorescence of MOLT-4 cells, which is related to their larger size. Similar results were obtained in a second independent experiment.
dependent on the presence of HIV since none were observed
whatever conditions used when uninfected MOLT-4 cells
were employed (Figure 4, left panels). These results strongly
suggest that CD4, once captured by CD8+ Tc e l l si s
virologically functional and can induce syncytia formation
with MOLT-4 cells.
3.5. HIV Infection of CD8+ T Cells Having Acquired CD4 by
Trogocytosis Remains Undetectable. To go one step further,
we next investigated if CD8+ T cells having acquired CD4
could be infected by HIV. For this, we used two experimental
approaches. First, we quantiﬁed the synthesis of proviral
DNA in the cocultures of MOLT-4 cells with CD8+ Tc e l l sJournal of Biomedicine and Biotechnology 7
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(low power ﬁelds) of cultures in which anti-CD3 + anti-CD28-activated CD8+ T cells that had been cocultured with HEK cells either
expressing CD4-GFP (middle and lower panels) or not (upper panels), were then mixed with uninfected MOLT-4 cells (left panels) or HIV-
infected MOLT-4 cells either in the absence (middle panels) or the presence (right panels) of the anti-CD4 mAb Leu3a. The controls shown
on the bottom panels correspond to T cells that have been cocultured with HEK cells expressing CD4-GFP, but had not previously been
activated with the anti-CD3 + anti-CD28 mAbs, (CTROL) white arrows indicate the positions of syncytia. (B) Quantiﬁcation of syncytia in
diﬀerent randomly selected high power ﬁelds. Data are mean ± SD values of at least four diﬀerent ﬁelds. Note that syncytia formation was
never detected when uninfected MOLT-4 cells were used, whatever the condition tested. Asterisks denote statistically signiﬁcant diﬀerences
between activated and control CD8+ T cells cocultured with HEK-CD4-GFP cells (P = .002, T test) and signiﬁcant inhibition was induced
by Leu3a (P = .001, T test).
described above, and we found no speciﬁc increases in HIV
proviral DNA associated with trogocytosis (not shown). This
was not, however, a very sensitive approach because infected
MOLT-4 already have a heavy load of proviral DNA, leading
to relatively high levels of background. As an alternative,
we evaluated whether CD8+ T cells, having acquired CD4
from HEK-FcR-CD4 target cells, may produce new HIV
particles after infecting them with the cell-free viruses (HIV
NL4-3 strain) and evaluating the level of HIV p24 Ag in
the supernatant after 5 days of culture. Low levels of p24
were detected in all samples, and we found no correlation
between the levels of p24 and the fact that CD8+ T cells had
capture CD4 or not by trogocytosis. Furthermore, addition
of inhibitors of the reverse transcriptase AZT or of the fusion
C34, failed to reduce the low levels of p24 observed in
control cultures (data not shown). These results suggest that,
although the presence of captured CD4 on the surface of
CD8+ T cells allows for binding of the virus, this may not
be enough to allow for productive infection of these cells by
HIV. Although these results were obviously disappointing to
us, many diﬀerent hypotheses can be proposed to explain
this observation. One possibility would be that CD8+ Tc e l l s
could replicate HIV but at levels too low to be detected. The
inability of CD8+ T cells to replicate HIV could be directly
related to their production of antiviral factors. For instance,
CD8+ Tcellsareknowntoproducehighamountsofantiviral
cytokines such as IFN-γ and MCP-1 which could result
in HIV being eliminated rather than replicated. Note that
CD8+ T cells used in our assays came from healthy donors,
whilst HIV+ CTL have been detected in patients having
reached the late stages of HIV infection. It is thus possible
that the altered status of CD8+ T cells observed among
seropositive patients could facilitate the virus replication in
these cells. Another possibility could be that CD8+ T cells are
naturally refractory to HIV infection. Although productive
HIV-infection of CD8+ T cell has been reported [10], our
data suggest that CD8+ T cells might block HIV replication
at some step between reverse transcription and expression
of viral proteins. This apparent paradox may be explained
by the reported requirement of speciﬁc envelope signals to
infect primary cells [35]. Yet another possible explanation
lies with the fact that, although the captured CD4 molecules
are correctly oriented, only a small proportion of those may
actually be fully inserted in the plasma membrane of the
CD8+ T cells. In support of this view, we recently showed
that FcR could be captured by T cells and could bind
ligand but do not apparently transmit intracellular signals
[32]. This result could be explained by our biochemical and
functional observations that the majority, if not all FcR were
not properly inserted in the plasma membrane of recipient
cells, though being correctly oriented, and hence were not
connected to the signaling machinery present in T cells.8 Journal of Biomedicine and Biotechnology
If a similar process applies for captured CD4, this could
explain why CD8+ T cells having captured CD4 are able to
bind HIV virions, but cannot be eﬃciently infected by the
virus.
In summary, although one cannot conclude from our
study that capture of CD4 by CTL via trogocytosis could
result in their infection, our results unravel a previously
unappreciated role for CTL during HIV infection that lies
with their ability to acquire CD4 by trogocytosis from the
cells they interact with. Furthermore, this mechanism could
play a role during HIV infection by promoting syncytia
formation, a mechanism postulated to contribute to CD4+
Tc e l ll o s s[ 36].
4. Conclusions
Through acquisition of the CD4 receptor from their target
cells, CD8+ T cells may play a previously unappreciated role
in HIV infection in binding the virus and favoring syncytia
formation. Remarkably, this can occur in the absence of
detectable infection of the CD8+ T cells by HIV. At this stage,
however, it remains unclear, whether our inability to detect
infection in CD8+ T cells was due to technical limitations or
if CD4 capture by CD8+ T cells never leads them to become
susceptible to a productive HIV infection. If this was the
case, explanation must therefore be sought to explain the
infection of CD8+ T cells in HIV-infected patients, such as
those published previously regarding transmission between
CD4+ cells [37, 38]o rf r o mC D 4 + cells to CD4− cells [39,
40]. Trogocytosis clearly occurs in vivo ([41] and references
therein). In the case of CD4, it is however unclear if the
fact that CD4 is sometimes found on CD8+ T cells can be
due to trogocytosis solely as de novo CD4 expression has
also been occasionally documented on activated CTL [13–
20]. Then, another aspect to determine is if the role of CD4
transfer via trogocytosis in syncytia formation which we
have documented in vitro is relevant during in vivo HIV
infection. The answer to this question is, however, currently
inaccessible, because we have no means to selectively block
trogocytosis. Further studies will be warranted to explore
whether additional roles could be played by trogocytic
acquisition of virologically-relevant molecules by CD8+ T
cells. Note that, as CD4 molecules are only transiently
displayed by CTL after capture, one can speculate that
functions due to trogocytosis could be controlled both
spatially and temporally. This notion suggests a particular
contextinwhichCD4capturedbyCTLcouldhavefunctional
consequences, which makes this process worth investigating.
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